Skip to content

Clinical trials

Drug-Related Side Effects and Adverse Reactions trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug-Related Side Effects and Adverse Reactions Country / region: United States Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20019
20022
20035
20046
20053
20067
20073
20084
20103
20112
20123
20133
20146
20154
20162
20171
20186
20198
20207
20219
20226
20234
20243
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Unknown status13
Recruiting9
Terminated9
Withdrawn8
Not yet recruiting4
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital7
VA Office of Research and Development5
Alliance for Clinical Trials in Oncology4
Cipherome, Inc.4
Duke University4
Tabula Rasa HealthCare4
University of Pittsburgh4
Genelex Corporation3
Indiana University3
Texas A&M University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug-Related Side Effects and Adverse Reactions139
Lung Neoplasms10
Breast Neoplasms9
Leukemia9
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Lymphoma8
Multiple Myeloma8
Radiation Injuries8
Neoplasms, Plasma Cell7
Carcinoma, Non-Small-Cell Lung6

Trials

Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.